An Exclusively Oral Ribavirin Regimen for Respiratory Syncytial Virus Infection after Lung Transplantation is Effective and Cost-Efficient
Autor: | Carlos, L.M., Burrows, F.S., Plit, M.L., Havryk, A.P., Benzimra, M., Pearson, R.F., Glanville, A.R., Darley, D.R., Thomson, C., Malouf, M.A. |
---|---|
Zdroj: | In Journal of Heart and Lung Transplantation April 2020 39(4) Supplement:S95-S95 |
Databáze: | ScienceDirect |
Externí odkaz: |